Skip to main content
Holiday Sale — Get 40% off Vantage for yourself or as a gift
Get Started
SubscribeLogin
Published • loading... • Updated

The new approach to HRT delivery

Summary by European Pharmaceutical Manufacturer
Charles Virden, founder and CEO of VitalTE, and Lisa Stehno-Bittel, president and founder of Likarda, discuss a new approach to HRT delivery that would allow self-administration through infrequent injection.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.Cross Cancel Icon

2 Articles

Dalmatinski portalDalmatinski portal

Continuation of the popular series 'Forever the Author' on HRT

Author: Toni Volarić

Read Full Article
European Pharmaceutical ManufacturerEuropean Pharmaceutical Manufacturer

The new approach to HRT delivery

Charles Virden, founder and CEO of VitalTE, and Lisa Stehno-Bittel, president and founder of Likarda, discuss a new approach to HRT delivery that would allow self-administration through infrequent injection.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

European Pharmaceutical Manufacturer broke the news in on Thursday, March 20, 2025.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Split icon

Split

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal